Finance

Lists
Why is 6OP down 3,42%?
Dive Deeper
6OP:FRA
Ose Immunotherapeutics SA
€2,20
-3,42%
(-0,078) 1D
30 ກ.ຍ., 8 ໂມງ 2 ນາທີ 11 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6OP...
Open
€2,20
High
€2,20
Low
€2,20
Mkt. cap
52,82 ລ້ານ
Avg. vol.
47,00
Volume
0,00
52-wk high
€7,16
52-wk low
€2,19
EPS
€-1,69
No. of employees
64
Open
€2,20
High
€2,20
Low
€2,20
Mkt. cap
52,82 ລ້ານ
Avg. vol.
47,00
Volume
0,00
52-wk high
€7,16
52-wk low
€2,19
EPS
€-1,69
No. of employees
64
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded17 ພ.ຈ. 2004
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ກ.ຍ. 2024
ທ.ວ. 2024
Revenue
431,00 ພັນ
431,00 ພັນ
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 ລ້ານ
8,28 ລ້ານ
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 ລ້ານ
1,08 ລ້ານ
Operating expense
10,22 ລ້ານ
10,22 ລ້ານ
Total operating expenses
10,22 ລ້ານ
10,22 ລ້ານ
Operating income
-9,79 ລ້ານ
-9,79 ລ້ານ
Other non operating income
-611,00 ພັນ
-611,00 ພັນ
EBT including unusual items
-10,44 ລ້ານ
-10,44 ລ້ານ
EBT excluding unusual items
-10,53 ລ້ານ
-10,53 ລ້ານ
Income tax expense
-576,50 ພັນ
-576,50 ພັນ
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 ພັນ
41,00 ພັນ
Net income
-9,86 ລ້ານ
-9,86 ລ້ານ
Net profit margin
-2.288,86%
-2.288,86%
Earnings per share
-
-
Interest and investment income
571,00 ພັນ
571,00 ພັນ
Interest expense
-707,50 ພັນ
-707,50 ພັນ
Net interest expenses
-136,50 ພັນ
-136,50 ພັນ
Depreciation and amortization charges
-
-
EBITDA
-9,74 ລ້ານ
-9,74 ລ້ານ
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google